In a year marked by sustained momentum in large-scale AI funding, Hippocratic AI stood out among U.S.-based startups raising $100 million or more in 2025. The company completed multiple major financing rounds, reflecting strong investor confidence in healthcare-focused AI agents as a durable, high-value category within the broader AI market. Its inclusion alongside leading infrastructure, research, and enterprise AI companies highlights the growing prominence of specialized, regulated-use AI platforms in late-stage funding activity.
Hippocratic AI announced a $141 million Series B round in January 2025 led by Kleiner Perkins, valuing the company at more than $1.6 billion, followed later in the year by a $126 million Series C round led by Avenir Growth at a $3.5 billion valuation. These raises underscore the company’s rapid scale-up and positioning as a healthcare AI unicorn, driven by demand for safety-focused, patient-facing AI agents that help health systems address staffing shortages and operational inefficiencies at enterprise scale.